AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
DIAGNOSTIC VALIDITY OF PULMONARY-ARTERY CATHETERIZATION FOR RESIDENTSAT AN INTENSIVE-CARE UNIT
Authors: STAUDINGER T LOCKER GJ LACZIKA K KNAPP S BURGMANN H WAGNER A WEISS K ZIMMERL M STOISER B FRASS M
Citation: T. Staudinger et al., DIAGNOSTIC VALIDITY OF PULMONARY-ARTERY CATHETERIZATION FOR RESIDENTSAT AN INTENSIVE-CARE UNIT, The journal of trauma, injury, infection, and critical care, 44(5), 1998, pp. 902-906
COMPETITIVE CBF-BETA MYH11 REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION FOR QUANTITATIVE ASSESSMENT OF MINIMAL RESIDUAL DISEASE DURING POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA WITH INVERSION(16) - A PILOT-STUDY/
Authors: LACZIKA K NOVAK M HILGARTH B MITTERBAUER M MITTERBAUER G SCHEIDELPETROVIC A SCHOLTEN C THALHAMMERSCHERRER R BRUGGER S KEIL F SCHWARZINGER I HAAS OA LECHNER K JAEGER U
Citation: K. Laczika et al., COMPETITIVE CBF-BETA MYH11 REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION FOR QUANTITATIVE ASSESSMENT OF MINIMAL RESIDUAL DISEASE DURING POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA WITH INVERSION(16) - A PILOT-STUDY/, Journal of clinical oncology, 16(4), 1998, pp. 1519-1525
EXPERIENCES WITH INHALATIVE NITRIC-OXIDE IN INTERNAL INTENSIVE-CARE PATIENTS WITH ARDS
Authors: STAUDINGER T MULLNER M WAGNER A LOCKER GJ LACZIKA K KNAPP S BURGMANN H STOISER B KOFLER J FRASS M
Citation: T. Staudinger et al., EXPERIENCES WITH INHALATIVE NITRIC-OXIDE IN INTERNAL INTENSIVE-CARE PATIENTS WITH ARDS, Acta medica austriaca, 25(2), 1998, pp. 53-56
COMPARISON OF OXYGEN COST OF BREATHING WITH PRESSURE-SUPPORT VENTILATION AND BIPHASIC INTERMITTENT POSITIVE AIRWAY PRESSURE VENTILATION
Authors: STAUDINGER T KORDOVA H ROGGLA M TESINSKY P LOCKER GJ LACZIKA K KNAPP S FRASS M
Citation: T. Staudinger et al., COMPARISON OF OXYGEN COST OF BREATHING WITH PRESSURE-SUPPORT VENTILATION AND BIPHASIC INTERMITTENT POSITIVE AIRWAY PRESSURE VENTILATION, Critical care medicine, 26(9), 1998, pp. 1518-1522
PROGNOSTIC VALUE OF MIP-1-ALPHA, TGF-BETA(2), SELAM-1, AND SVCAM-1 INPATIENTS WITH GRAM-POSITIVE SEPSIS
Authors: KNAPP S THALHAMMER F LOCKER GJ LACZIKA K HOLLENSTEIN U FRASS M WINKLER S STOISER B WILFING A BURGMANN H
Citation: S. Knapp et al., PROGNOSTIC VALUE OF MIP-1-ALPHA, TGF-BETA(2), SELAM-1, AND SVCAM-1 INPATIENTS WITH GRAM-POSITIVE SEPSIS, Clinical immunology and immunopathology, 87(2), 1998, pp. 139-144
TREMENDOUS HIGH PLASMA LIPOPOLYSACCHARIDE CONCENTRATIONS IN A PATIENTWITH LEGIONELLA-PNEUMOPHILA PNEUMONIA
Authors: LACZIKA K KNAPP S LOCKER GJ THALHAMMER F STOISER B FRASS M BURGMANN H
Citation: K. Laczika et al., TREMENDOUS HIGH PLASMA LIPOPOLYSACCHARIDE CONCENTRATIONS IN A PATIENTWITH LEGIONELLA-PNEUMOPHILA PNEUMONIA, Journal of endotoxin research, 4(4), 1997, pp. 301-304
PROGNOSTIC-SIGNIFICANCE OF WT1 GENE-EXPRESSION AT DIAGNOSIS IN ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: SCHMID D HEINZE G LINNERTH B TISLJAR K KUSEC R GEISSLER K SILLABER C LACZIKA K MITTERBAUER M ZOCHBAUER S MANNHALTER C HAAS OA LECHNER K JAGER U GAIGER A
Citation: D. Schmid et al., PROGNOSTIC-SIGNIFICANCE OF WT1 GENE-EXPRESSION AT DIAGNOSIS IN ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA, Leukemia, 11(5), 1997, pp. 639-643
PLASMA-EXCHANGE FOR TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENTS
Authors: KNOBL P RINTELEN C KORNEK G WILTSCHKE C KALHS P SCHWARZINGER I GLOBITS S STAUDINGER T LACZIKA K KYRLE P FRASS M
Citation: P. Knobl et al., PLASMA-EXCHANGE FOR TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENTS, Intensive care medicine, 23(1), 1997, pp. 44-50
EXOGENOUS SURFACTANT THERAPY IN A PATIENT WITH ADULT-RESPIRATORY-DISTRESS-SYNDROME AFTER NEAR-DROWNING
Authors: STAUDINGER T BANKIER A STROHMAIER W WEISS K LOCKER GJ KNAPP S ROGGLA M LACZIKA K FRASS M
Citation: T. Staudinger et al., EXOGENOUS SURFACTANT THERAPY IN A PATIENT WITH ADULT-RESPIRATORY-DISTRESS-SYNDROME AFTER NEAR-DROWNING, Resuscitation, 35(2), 1997, pp. 179-182
RESPIRATORY-FAILURE IN SYSTEMIC LUPUS-ERYTHEMATOSUS - DECISIVE DIFFERENTIATION BETWEEN ACUTE PNEUMONITIS AND INFECTION
Authors: STAUDINGER T ROGGLA M KETTENBACH J DEKAN G LOCKER GJ KNAPP S LACZIKA K ZIMMERL M GRANINGER W FRASS M
Citation: T. Staudinger et al., RESPIRATORY-FAILURE IN SYSTEMIC LUPUS-ERYTHEMATOSUS - DECISIVE DIFFERENTIATION BETWEEN ACUTE PNEUMONITIS AND INFECTION, British journal of rheumatology, 36(2), 1997, pp. 295-297
CENTRAL VENOUS CATHETERIZATION IN A PATIENT IN THE PRONE POSITION
Authors: SUNDERPLASSMANN G LOCKER GJ MUHM M THALHAMMER F LACZIKA K VONFRIEDENFELDT MF
Citation: G. Sunderplassmann et al., CENTRAL VENOUS CATHETERIZATION IN A PATIENT IN THE PRONE POSITION, Critical care medicine, 25(8), 1997, pp. 1439-1440
RENAL TOLERABILITY OF 4 DIFFERENT ONCE-DAILY DOSE REGIMEN OF NETILMICIN IN CRITICAL CARE PATIENTS
Authors: LACZIKA K STAUDINGER T HOLLENSTEIN U PRESTERL E LOCKER GJ KNAPP S BURGMANN H STOISER B KOFLER J WINTER W GRANINGER W FRASS M
Citation: K. Laczika et al., RENAL TOLERABILITY OF 4 DIFFERENT ONCE-DAILY DOSE REGIMEN OF NETILMICIN IN CRITICAL CARE PATIENTS, Wiener Klinische Wochenschrift, 109(21), 1997, pp. 840-844
DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY
Authors: THALHAMMER F GEISSLER K JAGER U KYRLE PA PABINGER I MITTERBAUER M GISSLINGER H KNOBL P LACZIKA K SCHNEIDER B HAAS OA LECHNER K
Citation: F. Thalhammer et al., DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY, Annals of hematology, 72(4), 1996, pp. 216-222
INFLUENCE OF PENTOXIFYLLINE ON CYTOKINE LEVELS AND INFLAMMATORY PARAMETERS IN SEPTIC SHOCK
Authors: STAUDINGER T PRESTERL E GRANINGER W LOCKER GJ KNAPP S LACZIKA K KLAPPACHER G STOISER B WAGNER A TESINSKY P KORDOVA H FRASS M
Citation: T. Staudinger et al., INFLUENCE OF PENTOXIFYLLINE ON CYTOKINE LEVELS AND INFLAMMATORY PARAMETERS IN SEPTIC SHOCK, Intensive care medicine, 22(9), 1996, pp. 888-893
INCREASED SERUM CONCENTRATION OF SOLUBLE CD14 IS A PROGNOSTIC MARKER IN GRAM-POSITIVE SEPSIS
Authors: BURGMANN H WINKLER S LOCKER GJ PRESTERL E LACZIKA K STAUDINGER T KNAPP S THALHAMMER F WENISCH C ZEDWITZLIEBENSTEIN K FRASS M GRANINGER W
Citation: H. Burgmann et al., INCREASED SERUM CONCENTRATION OF SOLUBLE CD14 IS A PROGNOSTIC MARKER IN GRAM-POSITIVE SEPSIS, Clinical immunology and immunopathology, 80(3), 1996, pp. 307-310
CLINICAL USE OF THE POLYMERASE CHAIN-REAC TION FOR DIAGNOSIS AND MONITORING OF MALIGNANT DISEASES
Authors: JAGER U LACZIKA K SCHOLTEN C MITTERBAUER M NOVAK M LECHNER K
Citation: U. Jager et al., CLINICAL USE OF THE POLYMERASE CHAIN-REAC TION FOR DIAGNOSIS AND MONITORING OF MALIGNANT DISEASES, Wiener Klinische Wochenschrift, 108(20), 1996, pp. 634-639
QUANTIFICATION OF CBF-BETA MYH11 FUSION TRANSCRIPTS BY COMPETITIVE RT-PCR POTENTIALLY PREDICTS PATIENT OUTCOME IN AML WITH INV(16)/
Authors: NOVAK M LACZIKA K HILGARTH B SCHEIDELPETROVIC A MITTERBAUER M LECHNER K JAEGER U
Citation: M. Novak et al., QUANTIFICATION OF CBF-BETA MYH11 FUSION TRANSCRIPTS BY COMPETITIVE RT-PCR POTENTIALLY PREDICTS PATIENT OUTCOME IN AML WITH INV(16)/, Blood, 88(10), 1996, pp. 2236-2236
KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SCHOLTEN C FODINGER M MITTERBAUER M LACZIKA K MITTERBAUER G HAAS OA KNOBL P SCHWARZINGER I THALHAMMER R PURTSCHER B GEISSLER K MANNHALTER C LECHNER K JAEGER U
Citation: C. Scholten et al., KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA, Annals of hematology, 71(4), 1995, pp. 155-160
CLEARANCE OF PCR-DETECTABLE LYMPHOMA-CELLS FROM THE PERIPHERAL-BLOOD,BUT NOT BONE-MARROW AFTER THERAPY WITH CAMPATH-1H
Authors: DELLEKARTH G LACZIKA K SCHOLTEN C LECHNER K JAEGER U SCHWARZINGER I SIMONITSCH I
Citation: G. Dellekarth et al., CLEARANCE OF PCR-DETECTABLE LYMPHOMA-CELLS FROM THE PERIPHERAL-BLOOD,BUT NOT BONE-MARROW AFTER THERAPY WITH CAMPATH-1H, American journal of hematology, 50(2), 1995, pp. 146-147
TETRIS AND PHYSICIANS PERFORMANCE STATE
Authors: LACZIKA K STAUDINGER T LOCKER GJ KNAPP S BURGMANN H FRASS M
Citation: K. Laczika et al., TETRIS AND PHYSICIANS PERFORMANCE STATE, Lancet, 346(8973), 1995, pp. 516-516
ANTIBODIES TO THE NONSTRUCTURAL PROTEIN OF PARVOVIRUS B19 IN PERSISTENTLY INFECTED PATIENTS - IMPLICATIONS FOR PATHOGENESIS
Authors: VONPOBLOTZKI A HEMAUER A GIGLER A PUCHHAMMERSTOCKL E HEINZ FX PONT J LACZIKA K WOLF H MODROW S
Citation: A. Vonpoblotzki et al., ANTIBODIES TO THE NONSTRUCTURAL PROTEIN OF PARVOVIRUS B19 IN PERSISTENTLY INFECTED PATIENTS - IMPLICATIONS FOR PATHOGENESIS, The Journal of infectious diseases, 172(5), 1995, pp. 1356-1359
PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: MITTERBAUER G FODINGER M SCHERRER R KNOBL P JAGER U LACZIKA K SCHWARZINGER I GAIGER A GEISSLER K GREINIX H KALHS P LINKESCH W LECHNER K MANNHALTER C
Citation: G. Mitterbauer et al., PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 89(4), 1995, pp. 937-941
NOVEL CBF-BETA-MYH11 FUSION TRANSCRIPTS AND ALTERNATIVE SPLICING IN ACUTE MYELOID-LEUKEMIA WITH INVERSION OF CHROMOSOME-16
Authors: NOVAK M LACZIKA K MITTERBAUER M PURTSCHER B SCHEIDELPETROVIC A LECHNER K JAEGER U
Citation: M. Novak et al., NOVEL CBF-BETA-MYH11 FUSION TRANSCRIPTS AND ALTERNATIVE SPLICING IN ACUTE MYELOID-LEUKEMIA WITH INVERSION OF CHROMOSOME-16, Blood, 86(6), 1995, pp. 2449-2450
RT-PCR MONITORING OF CBF-BETA-MYH11 IN PATIENTS WITH AML AND A CHROMOSOMAL INV(16) - VARIABLE BEHAVIOR OF THE CHIMERIC MESSENGER-RNA DURINGTREATMENT
Authors: NOVAK M LACZIKA K MITTERBAUER M SCHEIDELPETROVIC A HAAS OA LECHNER K JAEGER U
Citation: M. Novak et al., RT-PCR MONITORING OF CBF-BETA-MYH11 IN PATIENTS WITH AML AND A CHROMOSOMAL INV(16) - VARIABLE BEHAVIOR OF THE CHIMERIC MESSENGER-RNA DURINGTREATMENT, Blood, 86(10), 1995, pp. 1318-1318
MOLECULAR MECHANISM OF THE T(1418) - A MODEL FOR LYMPHOID-SPECIFIC CHROMOSOMAL TRANSLOCATIONS
Authors: JAEGER U DELLEKARTH G KNAPP S FRIEDL J LACZIKA K KUSEC R
Citation: U. Jaeger et al., MOLECULAR MECHANISM OF THE T(1418) - A MODEL FOR LYMPHOID-SPECIFIC CHROMOSOMAL TRANSLOCATIONS, Leukemia & lymphoma, 14(3-4), 1994, pp. 197-202
Risultati: 1-25 | 26-32